THE TERFENADINE BETA-CYCLODEXTRIN INCLUSION COMPLEX

被引:0
|
作者
REDENTI, E
PASINI, M
VENTURA, P
SPISNI, A
VIKMON, M
SZEJTLI, J
机构
[1] UNIV PARMA,IST CHIM BIOL,I-43100 PARMA,ITALY
[2] CYCLODEXTRIN RES & DEV LAB LTD,CYCLOLAB,H-1525 BUDAPEST,HUNGARY
来源
JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY | 1993年 / 15卷 / 03期
关键词
TERFENADINE; BETA-CYCLODEXTRIN; INCLUSION COMPLEX;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Terfenadine (TFN) is a very hydrophobic antiallergic drug. It exists in three polymorphic and two solvated forms and is practically insoluble in water. These properties make a pharmaceutical formulation with acceptable biopharmaceutical characteristics difficult to prepare. Inclusion complexation with beta-cyclodextrin (betaCD) may eliminate such problems. The properties of the TFN/betaCD system have been studied in liquid, gaseous and solid phases by H-1 and C-13 NMR spectroscopy, powder X-ray diffractometry, differential scanning calorimetry and fast atom bombardment mass spectrometry. The solubility phase diagram was also recorded. In solution and in the gaseous phase the 1 : 1 complex prevails, whereas a 1 : 2 TFN/betaCD complex has been isolated by precipitation from homogeneous solution.
引用
收藏
页码:281 / 292
页数:12
相关论文
共 50 条
  • [31] Determination of the stability constant for the inclusion complex between beta-cyclodextrin and nicotine using capillary electrophoresis
    Berglund, J
    Cedergren, L
    Andersson, SB
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 156 (02) : 195 - 200
  • [32] Preparation and Evaluation of Silymarin beta-cyclodextrin Molecular Inclusion Complexes
    Ghosh, A.
    Biswas, S.
    Ghosh, T.
    JOURNAL OF YOUNG PHARMACISTS, 2011, 3 (03) : 205 - 210
  • [33] The dimeric complex of beta-cyclodextrin with 1,13-tridecanedioic acid
    Makedonopoulou, S
    Tulinsky, A
    Mavridis, IM
    SUPRAMOLECULAR CHEMISTRY, 1999, 11 (01) : 73 - 81
  • [34] EFFECT OF PIROXICAM BETA-CYCLODEXTRIN COMPLEX ON EXPERIMENTAL INFLAMMATION
    AMADO, CAB
    TANIGUCHI, SF
    SUDO, LS
    KIMURA, E
    OGA, S
    GENERAL PHARMACOLOGY, 1995, 26 (04): : 809 - 813
  • [35] IMPROVED BIOAVAILABILITY FROM A SPIRONOLACTONE BETA-CYCLODEXTRIN COMPLEX
    YUSUFF, NT
    YORK, P
    CHRYSTYN, H
    BRAMLEY, PN
    SWALLOW, RD
    TULADHAR, BR
    LOSOWSKY, MS
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (05) : 507 - 511
  • [36] Solid state examination of a gliclazide:beta-cyclodextrin complex
    Winters, CS
    York, P
    Timmins, P
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 5 (04) : 209 - 214
  • [37] INTERACTION OF FLUORINATED ALCOHOLS WITH THE BETA-CYCLODEXTRIN ACRIDINE COMPLEX
    SCHUETTE, JM
    WARNER, IM
    ANALYTICAL LETTERS, 1994, 27 (06) : 1175 - 1182
  • [38] Effect of hydrophilic polymers on the solubility and dissolution enhancement of rivaroxaban/beta-cyclodextrin inclusion complexes
    Khan, Waqas Haider
    Asghar, Sajid
    Khan, Ikram Ullah
    Irfan, Muhammad
    Alshammari, Abdulrahman
    Rajoka, Muhammad Shahid Riaz
    Munir, Rabia
    Shah, Pervaiz A.
    Khalid, Ikrima
    Razzaq, Fizza Abdul
    Khalid, Syed Haroon
    HELIYON, 2023, 9 (09)
  • [39] Preparation and Evaluation of Domperidone/beta-Cyclodextrin/Citric Acid/Mannitol Quaternary Inclusion Complex: An In Vitro Study
    Ghorpade, Vishwajeet S.
    Remeth, Dias
    Kailas, Mali
    Vijay, Havaldar
    ASIAN JOURNAL OF PHARMACEUTICS, 2016, 10 (03) : S375 - S385
  • [40] STUDIES OF CYCLODEXTRIN INCLUSION COMPLEXES .3. THE PULMONARY ABSORPTION OF BETA-CYCLODEXTRIN, DM-BETA-CYCLODEXTRIN AND HP-BETA-CYCLODEXTRIN IN RABBITS
    MARQUES, HMC
    HADGRAFT, J
    KELLAWAY, IW
    TAYLOR, G
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 77 (2-3) : 297 - 302